Genomics

Dataset Information

0

M249 melanoma cells: Vemurafenib and Selumetinib resistant through BRAF double minutes vs. parental


ABSTRACT: CGH profiling of M249 melanoma cell line treated with step-wise increasing Vemurafenib and Selumetinib to develop resistance (VSR). The resistance mechanims was through BRAF amplification in double minute (DM) format. The control cell line is untreated M249.

ORGANISM(S): Homo sapiens

PROVIDER: GSE153526 | GEO | 2021/12/20

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA642898 | ENA
| PRJNA712989 | ENA
2020-12-19 | GSE134838 | GEO
2019-06-22 | E-MTAB-5493 | biostudies-arrayexpress
2019-03-11 | GSE126367 | GEO
2019-03-11 | GSE126109 | GEO
2023-02-16 | GSE178267 | GEO
2014-05-20 | GSE42872 | GEO
2021-09-12 | GSE183859 | GEO
2021-03-23 | GSE168602 | GEO